Zaky et al. reported that DPP-4 inhibition by vildagliptin in cholestatic sepsis resulted in increased GLP-1 levels, which reduced fever and ileal NF-κB, TNFα and myeloperoxidase [39]. This evidence concerns the gene NFKB1 and Sepsis.